Fact-checked by Grok 2 weeks ago

Nitrous oxide

Nitrous oxide (N₂O) is a colorless, non-flammable gas with a slightly sweet odor and taste, consisting of two nitrogen atoms bonded to one oxygen atom in a linear molecular structure. Known as laughing gas for its euphoric effects when inhaled, it was first isolated by Joseph Priestley in 1772 and systematically studied by Humphry Davy in the late 1790s, who demonstrated its analgesic properties through self-experimentation. In medicine, nitrous oxide serves as an inhalational anesthetic and analgesic, particularly in dentistry and procedural sedation, owing to its rapid onset, minimal respiratory depression, and quick recovery profile. It is also employed as a propellant in food aerosols, such as whipped cream dispensers, and as an oxidizer to enhance combustion in rocket motors and automotive engines. Atmospherically, nitrous oxide acts as a long-lived greenhouse gas with a 100-year global warming potential of 265 to 298 times that of carbon dioxide and contributes to stratospheric ozone depletion by breaking down into nitric oxide in the upper atmosphere.

Chemical and Physical Properties

Molecular Structure and Basic Characteristics

Nitrous oxide (N₂O) is a linear triatomic molecule with the central nitrogen atom bonded to one terminal nitrogen and one oxygen atom. The molecule exhibits resonance, with the dominant structure represented as N≡N⁺–O⁻, featuring a triple bond between the nitrogens and a single bond to oxygen with formal charges, alongside a minor contribution from N⁻–N⁺≡O. This resonance hybridization results in bond lengths of approximately 1.13 Å (N-N) and 1.19 Å (N-O), reflecting partial double-bond character and contributing to the molecule's chemical stability and oxidizing properties due to the electrophilic nitrogen. The molar mass is 44.013 g/mol. At standard temperature and pressure, nitrous oxide exists as a colorless, odorless, nonflammable gas. It has a melting point of −90.86 °C and a boiling point of −88.48 °C. The gas density at 0 °C and 1 atm is 1.977 g/L, approximately 1.53 times that of air. Solubility in water is low, at 1.2 g/L (0.0012 g/mL) at 20 °C and 1 atm. Thermodynamic properties include a critical temperature of 36.4 °C and critical pressure of 72.5 atm (7.25 MPa). The ideal gas heat capacity at constant pressure (Cp) is approximately 38.6 J/mol·K at 25 °C, increasing with temperature as described by the Shomate equation for gas-phase conditions. These attributes underscore its utility in compressed form while highlighting phase behavior under varying pressures and temperatures.

Reactivity and Stability

Nitrous oxide demonstrates high stability at standard temperature and pressure, showing minimal reactivity with air, water, or most organic materials, which distinguishes it from more labile nitrogen oxides. This inertness arises from its linear molecular structure and weak polarity, rendering it non-corrosive and suitable for long-term storage in compatible materials like steel or aluminum. However, it functions as a mild oxidizing agent, comparable in strength to hydrogen peroxide but superior to dioxygen, capable of supporting the combustion of flammable substances without igniting itself. Thermal decomposition represents the dominant reactivity pathway, proceeding via the endothermic dissociation $2\mathrm{N_2O} \rightarrow 2\mathrm{N_2} + \mathrm{O_2} with a standard enthalpy change of \Delta H = +164 kJ/mol (or +82 kJ/mol per mole of N₂O), driven by the release of stable N₂. This reaction initiates appreciably above 500 °C under atmospheric pressure, with rates increasing exponentially; for instance, significant decomposition occurs between 600–850 °C in the absence of catalysts. Metal surfaces, such as iron or copper, or certain contaminants like oils, can catalyze this process, lowering the activation energy and accelerating decomposition at reduced temperatures through surface-mediated oxygen atom abstraction. Nitrous oxide engages in limited direct reactions, including slow oxidation with alkali metals like sodium or potassium, where the metal atom abstracts an oxygen from N₂O, forming metal oxide and N₂; this proceeds via a collinear transition state with barriers around 10–20 kcal/mol depending on the metal. Such reactivity underscores its role as an oxygen donor rather than a reducing agent. Despite baseline stability, nitrous oxide exhibits sensitivity to extreme conditions, where rapid decomposition can generate explosive pressures from the evolved oxygen and heat—up to 20-fold volume expansion. Contaminants, including hydrocarbons or halocarbons, lower the decomposition threshold dramatically, sometimes to below 300 °C or even ambient temperatures in confined spaces, as impurities facilitate chain-propagating radicals. This hazard necessitates rigorous purification and temperature controls in storage cylinders to prevent autoignition or rupture.

Historical Development

Discovery and Initial Characterization

Joseph Priestley first isolated nitrous oxide in 1772 by heating a mixture involving ammonium nitrate, producing what he termed "nitrous air" or "phlogisticated nitrous air," though he did not fully characterize its properties or effects. Priestley's empirical method involved thermal decomposition, yielding the gas alongside other nitrogen oxides, but his observations focused primarily on its reactivity with reducing agents rather than its physiological impacts. In 1799, Humphry Davy systematically studied the gas at the Pneumatic Institution in Bristol, purifying it through repeated distillation and conducting self-experiments by inhaling it via inhalation bags. Davy named it "nitrous oxide" to distinguish it from nitric oxide and documented its euphoric effects, describing sensations of intense pleasure, heightened vividness of ideas, and muscular excitement during respiration trials from 1799 to 1800. These experiments, detailed in his 1800 publication Researches, Chemical and Philosophical, linked the gas to respiration studies, noting its potential to induce giddiness and emotional elevation without immediate toxicity when briefly inhaled. Early characterizations also revealed nitrous oxide's asphyxiant nature, as prolonged inhalation displaced oxygen, leading to hypoxia despite initial invigorating perceptions; Davy's trials highlighted this dual aspect, with subjects experiencing convulsions or unconsciousness in extended exposures. By the early 19th century, chemical analyses confirmed its molecular formula as N₂O through volumetric and gravimetric methods, solidifying its identity as a distinct oxide of nitrogen.

Early Industrial and Medical Applications

Horace Wells, an American dentist, pioneered the medical application of nitrous oxide on December 10, 1844, after attending a public demonstration by Gardner Quincy Colton in Hartford, Connecticut, where he observed a participant injure himself without apparent pain under the gas's influence. Wells self-administered nitrous oxide the following day for the extraction of his own molar, experiencing no pain, and subsequently used it successfully on several patients for dental procedures. Although an attempt to demonstrate it publicly in Boston shortly thereafter failed due to improper administration and patient movement, this event marked the initial clinical use of nitrous oxide for analgesia in dentistry. By the 1860s, nitrous oxide achieved broader adoption in surgical and dental practices across the United States, driven by Colton's promotion through lectures, clinics, and training of over 15,000 practitioners, which facilitated its integration into routine extractions and minor operations. Efficacy remained variable, however, as pure nitrous oxide often induced incomplete anesthesia or hypoxia from oxygen displacement, limiting its reliability without adjuncts like ether and contributing to sporadic failures in early applications. This variability stemmed from inadequate dosing and delivery systems, yet the gas's rapid onset and short duration positioned it as a practical alternative to ether for short procedures where flammability risks were a concern. Industrial production of nitrous oxide scaled in the late 19th century to meet growing medical demand, with facilities established for thermal decomposition of ammonium nitrate, enabling reliable supply for clinical use. Early non-medical applications included experimental use as an oxidizer in engines, though significant deployment occurred during World War II, when the German Luftwaffe incorporated nitrous oxide in the GM-1 system to boost aircraft engine power by up to 100 horsepower through enhanced oxygen supply, compensating for fuel limitations without raising detonation risks. This wartime innovation highlighted nitrous oxide's utility as a monopropellant for temporary performance gains in piston engines. Post-World War II refinements standardized medical administration as mixtures with oxygen, typically 50% nitrous oxide and 50% oxygen (Entonox), to avert hypoxia while preserving analgesic effects, improving safety margins and enabling wider surgical adoption. These mixtures addressed earlier limitations by maintaining adequate oxygenation, with production processes optimized for purity to minimize contaminants that could exacerbate variability.

Production Processes

Industrial Synthesis

The primary industrial method for synthesizing nitrous oxide (N₂O) entails the controlled thermal decomposition of ammonium nitrate (NH₄NO₃). This process involves heating an aqueous solution of ammonium nitrate, typically at concentrations of 80–93%, to temperatures between 250–280 °C, yielding N₂O and water vapor via the exothermic reaction NH₄NO₃ → N₂O + 2H₂O. Precise temperature control is essential to prevent uncontrolled decomposition or detonation risks inherent to ammonium nitrate. The resulting gas mixture, containing N₂O along with impurities such as water vapor, nitric oxide (NO), and nitrogen dioxide (NO₂), undergoes purification. This includes condensation to remove water, alkaline scrubbing to eliminate nitrogen oxides, and fractional distillation to achieve purities exceeding 99%. Byproduct management focuses on capturing and recycling unreacted ammonium nitrate or neutralizing acidic effluents, with typical material efficiency requiring 1.8–2 kg of ammonium nitrate per kg of N₂O produced. Alternative methods, such as decomposition in chloride-containing nitric acid solutions or recovery as a byproduct from adipic acid or nitric acid production, exist but are less prevalent due to lower yields and higher complexity compared to the ammonium nitrate route. Global production capacity supports an estimated annual output of approximately 0.5 million metric tons of commercial-grade N₂O as of 2023, scaled by market demand for medical, food, and propulsion applications. The process's scalability stems from its exothermic nature, minimizing external energy inputs beyond initial heating and compression for liquefaction, contributing to production costs around $0.50–1.00 per kg at scale, primarily driven by raw material expenses.

Laboratory Preparation

Nitrous oxide is commonly prepared in laboratories through the controlled thermal decomposition of dry ammonium nitrate, following the reaction NH₄NO₃ → N₂O + 2H₂O. This process requires heating the reagent to temperatures between 170°C and 270°C in a suitable apparatus, such as a distillation flask equipped with a condenser, to generate the gas while minimizing side reactions that could produce nitrogen or nitric oxide at higher temperatures. The resulting gas is typically collected by displacement of water or air, then purified via fractional distillation under reduced pressure or by passing through drying agents like concentrated sulfuric acid to remove moisture and impurities, ensuring high purity suitable for analytical or educational purposes. This batch-wise approach allows for precise control over reaction conditions in glassware setups, differing from industrial continuous-flow processes by prioritizing small-scale yield optimization—often achieving 80-90% efficiency through careful temperature regulation—and enabling immediate spectroscopic verification of product identity. Safety protocols are critical, as ammonium nitrate decomposition can accelerate explosively if overheated beyond 300°C or contaminated, necessitating operations in a well-ventilated fume hood with remote heating and pressure relief mechanisms. An alternative laboratory route involves the reaction of sulfamic acid with nitric acid, which generates nitrous oxide via intermediate formation of nitrosylsulfamic acid, though this method carries risks of uncontrolled gas evolution and is less favored for routine use due to its hazardous nature.

Natural Occurrence and Biogeochemical Cycle

Atmospheric Concentrations and Trends

Atmospheric concentrations of nitrous oxide (N₂O) prior to the Industrial Revolution were approximately 270 parts per billion (ppb), based on ice core records spanning the past 800,000 years where levels rarely exceeded 280 ppb. By May 2025, global average concentrations reached 338.66 ppb, reflecting a roughly 25% increase since pre-industrial times, as measured by the NOAA Global Monitoring Laboratory at sites like Mauna Loa. The long-term trend shows a steady rise driven by anthropogenic emissions outpacing natural removal processes, with N₂O's atmospheric lifetime estimated at 116 ± 9 years, primarily due to stratospheric photolysis and oxidation. This accumulation contributes about 6% to the total radiative forcing from long-lived anthropogenic greenhouse gases since 1750. Annual growth rates have averaged 0.8–1 ppb per year over recent decades but accelerated post-2020, reaching 1.32 ppb in 2020 and 1.29 ppb in 2021—the highest observed since systematic monitoring began in the late 1970s—consistent with intensified global nitrogen inputs enhancing net production. Isotopic analysis of the ¹⁵N/¹⁴N ratio in atmospheric N₂O provides a tracer for distinguishing emission origins and transformation pathways, revealing shifts toward lighter signatures (more depleted in ¹⁵N) that align with increased microbial production under elevated nitrogen availability. These site preference and bulk δ¹⁵N values, derived from high-precision measurements, confirm that recent trend accelerations reflect imbalances in the global N₂O budget rather than changes in atmospheric sinks.

Emission Sources and Biological Pathways

Nitrous oxide (N₂O) emissions arise predominantly from microbial processes in the nitrogen cycle, where bacteria and fungi in soils, sediments, and aquatic systems produce the gas as a byproduct or intermediate. Nitrification, an aerobic oxidation of ammonium (NH₄⁺) to nitrate (NO₃⁻), generates N₂O primarily during the partial oxidation of hydroxylamine (NH₂OH) to nitrite (NO₂⁻) by ammonia-oxidizing organisms such as Nitrosomonas species. Denitrification, an anaerobic dissimilatory process, reduces NO₃⁻ stepwise to N₂, releasing N₂O when enzymes like nitrous oxide reductase are substrate-limited or inhibited, often under low oxygen and high nitrate conditions; this pathway dominates in waterlogged soils and oxygen minimum zones (OMZs) of oceans. These processes are regulated by environmental factors including temperature, pH, oxygen levels, and nitrogen availability, with incomplete denitrification yielding higher N₂O yields under fluctuating redox conditions. Chemodenitrification—abiotic reactions of reduced nitrogen compounds like NO₂⁻ with soil organics or metals—and nitrifier denitrification (hybrid aerobic reduction by nitrifiers) contribute smaller fractions globally. Global N₂O emissions totaled approximately 18 Tg N yr⁻¹ during 2010–2019, with natural sources comprising 65% (11.8 Tg N yr⁻¹) and anthropogenic sources 35% (6.5 Tg N yr⁻¹). Natural emissions stem chiefly from unfertilized soils (6.4 Tg N yr⁻¹), where microbial nitrification and denitrification occur in forest, grassland, and wetland ecosystems, modulated by organic matter decomposition and precipitation patterns. Oceanic sources add about 4.7 Tg N yr⁻¹ (open ocean 3.5 Tg N yr⁻¹ plus shelves 1.2 Tg N yr⁻¹), concentrated in tropical OMZs via denitrification and nitrifier activity amid upwelling nutrient-rich waters. Anthropogenic emissions, while representing a minority of the total, have risen 40% since 1980 due to intensified nitrogen cycling. Agricultural soils account for the largest share, with direct emissions from synthetic fertilizers and manure (3.6 Tg N yr⁻¹) stimulating excess nitrification and denitrification in cropped fields, where excess ammonium and nitrate applications exceed plant uptake. This sector comprises 56% of anthropogenic emissions, as nitrogen inputs amplify microbial rates beyond natural baselines. Industrial sources, including nitric acid production for fertilizers and adipic acid synthesis for nylon, contribute under 0.5 Tg N yr⁻¹ (<5% of anthropogenic total), via side reactions like ammonium nitrate decomposition. Minor anthropogenic fluxes arise from fossil fuel combustion (~0.2 Tg N yr⁻¹), biomass burning, and wastewater, where incomplete denitrification in anaerobic digesters releases N₂O. Indirect emissions from atmospheric nitrogen deposition and leaching (1.2 Tg N yr⁻¹) further enhance natural soil and aquatic processes. Temperature increases from climate change accelerate soil microbial respiration, elevating N₂O production rates via higher enzyme kinetics in both nitrification (Q₁₀ ~1.5–2) and denitrification (Q₁₀ up to 3), fostering positive feedback where warming boosts emissions by 10–50% per °C in many ecosystems. Enhanced fertilizer application efficiencies, such as precision timing and slow-release formulations, however, reduce N₂O yield per unit nitrogen input by limiting substrate excess for microbial processes.

Industrial and Technical Applications

Propulsion and Performance Enhancement

Nitrous oxide functions as an oxidizer in propulsion systems by decomposing exothermically into nitrogen and oxygen, thereby supplying additional oxygen for combustion and releasing heat that augments thrust. This property makes it suitable for hybrid rocket motors, where it is vaporized and injected over a solid fuel grain, such as hydroxyl-terminated polybutadiene (HTPB), to control the regression rate and achieve throttlable performance. In rocketry, nitrous oxide enabled the SpaceShipOne spacecraft to complete the first private crewed suborbital flight on June 21, 2004, using a hybrid motor that generated sufficient thrust—estimated at around 76,000 pounds-force at peak—to propel the vehicle to an altitude of 367,441 feet. Hybrid configurations with nitrous oxide typically deliver specific impulses of 200 to 250 seconds at sea level, benefiting from the oxidizer's self-pressurizing characteristics that simplify feed systems compared to cryogenic alternatives. The decomposition reaction enhances effective thrust by providing both mass flow and thermal energy, potentially increasing performance over pure oxidizer-fuel systems, though actual gains depend on mixture ratio and chamber pressure. Despite these advantages, nitrous oxide's use in rocketry carries detonation risks from uncontrolled decomposition, which can escalate to explosion if triggered by contaminants like iron oxide or elevated temperatures exceeding 565°C, leading to pressure spikes that rupture tanks. Relative to liquid oxygen (LOX), nitrous oxide offers non-cryogenic storage and lower handling complexity, reducing boil-off losses, but yields lower specific impulse due to its higher molecular weight exhaust products and demands careful mixture ratio control to avoid efficiency drops. LOX, while requiring cryogenic infrastructure, supports higher performance in bipropellant systems but introduces risks like frostbite and oxygen fires. In automotive applications, nitrous oxide injection systems—branded as NOS—deliver the gas into the engine intake manifold, where it decomposes to enrich oxygen content, permitting up to 50-200% more fuel to be burned and boosting horsepower by 50 to 250 units in typical street setups. This oxygen augmentation allows internal combustion engines to exceed their naturally aspirated limits temporarily, with power gains scaling by injection volume: a 100-horsepower shot might add 100 horsepower, while larger 500-horsepower kits suit high-output racing engines. The technique traces to World War II German Luftwaffe aircraft experiments for high-altitude power, but gained prominence in U.S. drag racing from the late 1940s, where early adopters like those in Southern California hot rod circles achieved quarter-mile elapsed times under 12 seconds, outpacing supercharged rivals. By the 1970s, commercialized NOS kits from innovators like Mike Thermos dominated classes such as Pro Modified, enabling consistent sub-7-second runs and solidifying nitrous as a cost-effective, bolt-on enhancer for drag-and-drive events. Systems require precise solenoid timing and bottle pressure management (typically 900-1,100 psi) to prevent backfires or uneven delivery, with popularity enduring due to affordability—kits starting under $500—versus turbocharging or supercharging.

Food Processing and Aerosol Uses

Nitrous oxide functions as a propellant in whipped cream dispensers, where its high solubility in the fat content of cream—greater than that of nitrogen or oxygen—enables it to dissolve under pressure (typically 5-10 bar), forming stable microbubbles upon release that expand the foam volume up to four times the original liquid. This solubility follows Henry's law, with the dissolved gas concentration proportional to its partial pressure, ensuring uniform dispersion without acidic off-flavors from alternatives like carbon dioxide. The U.S. Food and Drug Administration authorizes nitrous oxide for direct food use in applications such as whipped cream production, deeming it safe when employed as a propellant in contained systems. Global annual sales of nitrous oxide cream chargers surpass 250 million units, predominantly for culinary foaming in the food industry. In modified atmosphere packaging (MAP), nitrous oxide supplements common gases like nitrogen and carbon dioxide by displacing oxygen to curb oxidation, microbial growth, and produce respiration, extending shelf life for items such as fresh fruits and vegetables. Food-grade nitrous oxide demand underscores its role in preservation, with the sector driving significant market volume amid controlled release that limits atmospheric emissions.

Medical and Pharmacological Applications

Clinical Uses in Anesthesia and Pain Management

Nitrous oxide serves as an adjunct in general anesthesia for surgical procedures, where concentrations of 50-70% in oxygen mixtures accelerate the onset of other inhaled anesthetics via the second gas effect and provide mild analgesia with rapid equilibration (onset within 2-5 minutes). Due to its high minimum alveolar concentration (approximately 104%), it lacks sufficient potency for standalone anesthesia and must be combined with potent agents like opioids or volatiles to achieve adequate depth, reducing overall requirements for these adjuvants by 20-30% in balanced techniques. In dentistry, nitrous oxide-oxygen mixtures (30-70%) are widely used for conscious sedation during procedures such as extractions and restorations, effectively reducing patient anxiety and procedural pain scores on visual analog scales by 20-50% compared to placebo or alternative sedatives like midazolam. Success rates for completing dental interventions under this sedation exceed 90% in pediatric and adult populations, with self-administration minimizing overdose risks. For labor analgesia, a fixed 50% N₂O/50% O₂ mixture, self-administered intermittently via demand valve mask, offers moderate pain relief, decreasing VAS scores by 3-5 points on a 10-point scale without impairing maternal mobility or fetal outcomes. Efficacy is comparable to systemic opioids but inferior to neuraxial blocks, with 40-60% of users reporting satisfactory relief despite higher dissatisfaction rates than epidural alternatives. Employed clinically since the 1840s, nitrous oxide maintains a favorable safety profile in controlled settings, with serious adverse events below 1% and mostly mild effects like nausea (rates <5-8%) resolving post-discontinuation. Recent advancements include portable, IoT-enabled delivery devices for ambulatory and emergency use, enabling real-time monitoring of gas flow, patient vitals, and automated safety cutoffs to enhance precision and reduce exposure variability as of 2025.

Mechanism of Action

Nitrous oxide exerts its primary pharmacological effects through central nervous system interactions, acting as a non-competitive antagonist at N-methyl-D-aspartate (NMDA) glutamate receptors, which inhibits excitatory neurotransmission and contributes to analgesia and mild anesthesia. This NMDA blockade occurs at clinically relevant concentrations, reducing ionic currents and protecting against excitotoxic damage without significantly potentiating inhibitory gamma-aminobutyric acid type A (GABAA) receptors, distinguishing it from other inhalational agents. Additionally, nitrous oxide modulates endogenous opioid systems by stimulating opioid peptide release in the periaqueductal gray matter of the midbrain, which activates descending noradrenergic inhibitory pathways to enhance antinociception and anxiolysis. It also influences dopaminergic pathways, potentially amplifying reward and analgesic responses, though these effects are secondary to NMDA antagonism. Unlike volatile anesthetics, nitrous oxide produces minimal respiratory depression at subanesthetic doses used for analgesia, preserving ventilatory drive due to its weak potency and selective neural targeting. The potency of nitrous oxide is quantified by its minimum alveolar concentration (MAC) of approximately 104%, indicating the alveolar partial pressure required to prevent movement in 50% of subjects to surgical stimulus, which underscores its role as an adjunct rather than a sole agent. Effects correlate directly with inhaled partial pressure, with rapid onset and equilibration facilitated by its low blood:gas partition coefficient of 0.47, allowing quick diffusion across the blood-brain barrier and minimal accumulation in tissues. This low solubility contrasts with more lipid-soluble volatiles, enabling faster induction and emergence without prolonged hangover effects. Nitrous oxide undergoes negligible metabolism in humans, with less than 0.004% biotransformed, primarily via cytochrome P450 enzymes under hypoxic conditions; the vast majority is exhaled unchanged through the lungs, supporting swift recovery proportional to alveolar ventilation. This pharmacokinetic profile minimizes accumulation and active metabolites, differentiating it from agents prone to hepatic processing or tissue redistribution, and aligns its central effects tightly with exposure duration.

Recreational Use and Associated Risks

Patterns of Abuse

Non-medical inhalation of nitrous oxide, often termed "whippits," typically involves discharging gas from small whipped cream charger canisters into balloons for inhalation or direct mouth inhalation using makeshift devices. Users commonly obtain canisters marketed for food preparation, with brands like Galaxy Gas gaining popularity through social media platforms such as TikTok starting around 2023, promoting flavored variants and party uses that facilitated wider diversion. Prevalence data indicate significant lifetime exposure among youth, with a 2010 U.S. adolescent survey reporting 15.8% lifetime use, while the 2023 National Survey on Drug Use and Health documented over 13 million Americans with lifetime misuse. Self-reported surveys highlight episodic patterns, particularly among those aged 16-24, driven by accessibility and social normalization at events. Recreational motivations center on short-lived euphoria and dissociative effects achieved via inhalation volumes equivalent to 1-2 liter balloons, producing sensations of floating or altered perception lasting seconds to minutes. Use patterns skew toward infrequent, social contexts like music festivals and nightclubs, where balloons are shared among groups, often alongside other substances, though some individuals exhibit repeated dosing in sessions. Over-the-counter availability of culinary chargers has sustained supply, with the global nitrous oxide cream charger market valued at approximately $510 million in 2025 and projected to reach $1 billion by 2035 at a 6.9% CAGR, reflecting demand growth that indirectly supports diversion despite emerging age-based sales restrictions in select U.S. states.

Health Consequences and Recent Mortality Trends

Recreational nitrous oxide abuse primarily causes neurological damage through irreversible oxidation of vitamin B12's cobalt ion, disrupting methionine synthase and methylmalonyl-CoA mutase activity, which impairs myelin synthesis and leads to subacute combined degeneration (SCD) of the spinal cord. This manifests as progressive sensory ataxia, paresthesia, and weakness, often mimicking B12 deficiency syndromes, with case studies reporting myeloneuropathy in heavy users after weeks to months of inhalation. Peripheral neuropathy affects sensory and motor nerves, predominantly axonal, with electrophysiologic evidence of slowed conduction velocities in chronic abusers. While exact prevalence varies, series indicate neuropathy or myelopathy in a substantial fraction of documented chronic cases, estimated at 20-50% based on aggregated clinical reports of persistent users inhaling hundreds of canisters weekly. Long-term sequelae include dorsal column degeneration visible on spinal MRI as T2 hyperintensities, potentially progressing to irreversible paraplegia or cognitive impairment if untreated, though early cessation and high-dose B12 supplementation can reverse symptoms in milder instances via restored enzyme function. Psychiatric effects, such as psychosis or mood disturbances, arise from combined hypoxic and metabolic disruptions, with some users experiencing hallucinations or dependency after prolonged exposure. Severe cases report permanent disability, underscoring causality from B12 inactivation rather than direct toxicity, as confirmed by elevated homocysteine and methylmalonic acid levels in affected individuals. Acute risks stem from hypoxia and asphyxia during inhalation, as nitrous oxide displaces oxygen without warning symptoms, leading to sudden cardiac arrhythmias, seizures, or coma. In the United States, deaths attributed to nitrous oxide poisoning rose from 23 in 2010 to 156 in 2023 among ages 15-74, a 578% increase, totaling 1,240 fatalities over the period, with asphyxia and acute neurological events predominant mechanisms. This surge correlates with wider availability of small canisters for recreational use, amplifying overdose potential in unsupervised settings, though underreporting may inflate true trends given reliance on death certificate data.

Safety and Toxicity Profile

Acute and Chronic Exposure Effects

Acute exposure to nitrous oxide primarily manifests as central nervous system depression and acts as a simple asphyxiant, with symptoms including dizziness, nausea, headache, and euphoria at concentrations above 50% when inhaled without supplemental oxygen. Higher levels, exceeding 70-80%, can lead to loss of consciousness, seizures, and death due to hypoxia from oxygen displacement rather than direct cellular toxicity. Animal lethality data underscore its relatively low inherent toxicity, with median lethal concentrations (LC50) in rodents requiring prolonged exposure to near-pure gas (e.g., 20-30% for hours), emphasizing anoxic mechanisms over chemical poisoning. The dose-response threshold for acute effects aligns with partial pressure equivalents; brief exposures below 25% with adequate oxygenation typically produce reversible analgesia without significant toxicity, but unsupervised high-dose inhalation risks rapid deoxygenation and cardiovascular instability. Chronic exposure, often occupational, inactivates vitamin B12-dependent methionine synthase, potentially leading to megaloblastic bone marrow depression, leukopenia, and neurological deficits such as peripheral neuropathy or subacute combined degeneration after months to years at elevated levels without folate supplementation. Hematologic changes, including reduced leukocyte motility and chemotaxis, have been observed in exposed healthcare workers, indirectly impairing immunity, though subclinical effects predominate at trace concentrations. Reproductive outcomes remain debated; early studies linked unscavenged occupational exposure (e.g., >75 ppm) in female dental assistants to increased spontaneous abortions and reduced fertility, but confounding factors like co-anesthetics and poor ventilation limit causality, with modern scavenged environments showing no consistent deficits. Regulatory thresholds mitigate risks: NIOSH recommends a 25 ppm time-weighted average (TWA) over 10 hours for waste anesthetic gas exposure to avert chronic effects, while ACGIH suggests 50 ppm TWA, with medical protocols emphasizing continuous monitoring, ventilation, and oxygen co-administration to maintain margins below these limits.

Occupational and Handling Hazards

Nitrous oxide poses risks as a simple asphyxiant in occupational settings, particularly in confined spaces where it can displace oxygen and lead to suffocation without warning symptoms due to its colorless, odorless nature. Exposure to high concentrations can cause dizziness, unconsciousness, and death by hypoxia. As a strong oxidizing agent, it supports combustion more vigorously than atmospheric oxygen, increasing fire and explosion hazards when in contact with flammable contaminants like oils, greases, or organic materials in cylinders or equipment. In production and handling, cylinder failures have occurred due to overpressurization, contamination, or improper storage, with notable incidents including a 2010s workplace explosion from a venting nitrous oxide-saline mixture that injured multiple workers. Such events underscore the need for purity standards to prevent decomposition reactions that generate pressure and heat. In medical environments like dentistry and surgery, chronic low-level exposure to unscavenged waste gases has been associated with potential reproductive and neurological effects in older studies, but meta-analyses of modern practices with exposure limits below 25 ppm show no consistent deficits when engineering controls are applied. Mitigation relies on engineering controls such as scavenging systems, local exhaust ventilation, and leak detection to maintain ambient levels below recommended thresholds like the NIOSH 25 ppm guideline or health-based limits of 20 mg/m³ (approximately 14 ppm) as an 8-hour time-weighted average. Personal protective equipment includes chemical-resistant gloves, eye protection meeting ANSI/ISEA Z87.1 standards, and self-contained breathing apparatus for high-risk handling or emergencies. Training emphasizes secure cylinder storage away from heat sources, compatibility with non-combustible materials, and protocols to avoid oil contamination during maintenance. Incidents remain rare with adherence to these standards, highlighting the efficacy of proactive purity and pressure management.

Environmental Impacts

Contribution to Climate Change

Nitrous oxide (N₂O) acts as a long-lived greenhouse gas, absorbing infrared radiation primarily in the 7.7–8.0 μm and 16–17 μm spectral regions, contributing to atmospheric warming through enhanced radiative forcing. Its global warming potential (GWP) is 273 relative to CO₂ over a 100-year timescale, reflecting its potency despite lower concentrations compared to CO₂ or methane (CH₄). This metric accounts for N₂O's radiative efficiency and atmospheric lifetime of approximately 109–121 years, during which it persists until photolysis or reaction with atomic oxygen in the stratosphere breaks it down. Anthropogenic N₂O emissions contribute about 6.4% to the total effective radiative forcing from well-mixed greenhouse gases since 1750, a share dwarfed by CO₂ (around 66%) and CH₄ (about 16%). Human activities generate roughly 40% of global N₂O emissions, with the remainder from natural sources like soils and oceans; within anthropogenic emissions, agriculture dominates at 70–75%, driven by microbial denitrification and nitrification in fertilized soils and manure management, while medical, industrial, and fuel combustion sources each comprise less than 1–3%. This sectoral imbalance underscores N₂O's climate role as tied predominantly to agronomic nitrogen inputs rather than dispersed industrial processes. Atmospheric N₂O concentrations reached 338.0 ppb in 2024, up 1.0 ppb from 2023, with a multidecadal growth rate of approximately 0.8–1.0 ppb per year that has remained linearly consistent without observed tipping points or nonlinear accelerations. Observed trends align with emission inventories, showing no deviation from steady-state increases attributable to expanding agricultural nitrogen use.

Ozone Layer Interactions and Broader Ecosystem Effects

In the stratosphere, nitrous oxide (N₂O) serves as the primary source of nitrogen oxides (NOx), which catalyze ozone (O₃) destruction through a series of reactions. N₂O, with an atmospheric lifetime of approximately 116 years, reaches the stratosphere largely intact and undergoes destruction primarily via photolysis or reaction with excited oxygen atoms (O(¹D)), producing nitric oxide (NO): N₂O + O(¹D) → 2NO. The NO then participates in catalytic cycles, such as NO + O₃ → NO₂ + O₂ followed by NO₂ + O → NO + O₂, resulting in net ozone loss: O₃ + O → 2O₂. These processes occur most efficiently in the middle stratosphere, where NOx from N₂O contributes significantly to ozone depletion. Following the phase-out of chlorofluorocarbons (CFCs) and other synthetic ozone-depleting substances under the Montreal Protocol, anthropogenic N₂O has emerged as the dominant ozone-depleting emission, accounting for the largest ongoing threat to stratospheric ozone recovery. Natural N₂O emissions provide a baseline, but human activities have increased concentrations by about 20% since pre-industrial levels, sustaining depletion pressures despite reductions in halocarbons. Without controls on N₂O, projections indicate it will remain the primary anthropogenic contributor through the 21st century. Beyond stratospheric effects, N₂O emissions disrupt terrestrial and aquatic ecosystems through linkages in the nitrogen cycle. Excess nitrogen inputs from agriculture, such as fertilizers, drive denitrification processes that emit N₂O while contributing to eutrophication via nitrate runoff and atmospheric deposition of NOx precursors derived from related microbial pathways. In eutrophic waters, high nitrate levels promote incomplete denitrification, elevating N₂O yields and exacerbating hypoxia and algal blooms. Soil microbial communities, particularly denitrifying bacteria, respond to warming by accelerating N₂O production, creating feedbacks where elevated temperatures enhance emissions from thawing permafrost and fertilized soils, potentially amplifying nitrogen losses.

Regulatory Framework and Debates

Global and National Legal Status

Nitrous oxide is not scheduled as a controlled substance under United Nations conventions on psychotropic substances or narcotic drugs, remaining legal for legitimate industrial, medical, agricultural, and culinary uses across all countries. However, many jurisdictions monitor its distribution to prevent recreational misuse, with restrictions typically targeting sales for human inhalation rather than commodity applications. International trade in nitrous oxide for non-recreational purposes encounters no blanket prohibitions, though exports of related agricultural precursors like ammonium nitrate may face national security or environmental controls in select cases. In the United States, nitrous oxide holds no federal scheduling under the Drug Enforcement Administration's Controlled Substances Act, permitting its production and sale as an unregulated chemical commodity for industrial and food uses. The Food and Drug Administration oversees its purity and labeling for medical anesthesia and propellant applications, while twelve states explicitly ban sales or possession intended for recreational inhalation. The United Kingdom classified nitrous oxide as a Class C drug under the Misuse of Drugs Act 1971 effective November 8, 2023, criminalizing possession, supply, production, import, or export for purposes other than authorized uses like industry or medicine. In the European Union, no unified ban exists, but member states enforce varying controls; for instance, the Netherlands prohibited possession, import, and sale for recreational purposes starting January 1, 2023. Australia deems the sale of nitrous oxide for human consumption a criminal offense under federal law, with states imposing additional limits such as age restrictions on purchases and prohibitions on non-therapeutic supply. Western Australia amended its Medicines and Poisons Regulations 2016 effective October 31, 2024, to bar public access for non-legitimate ends, while Victoria reclassified non-therapeutic products as Schedule 6 poisons from October 1, 2022.

Controversies Over Bans and Mitigation Strategies

Proponents of recreational bans emphasize nitrous oxide's role in public health crises, including neurological damage and fatalities from heavy misuse, which prompted the UK government's classification of the substance as a Class C drug effective November 8, 2023, with penalties up to two years imprisonment for repeat possession offenses intended for inhalation. This measure addressed rising antisocial use and hospital admissions, yet critics, including medical experts and harm reduction advocates, contend it disproportionately burdens law enforcement while discouraging affected users from seeking timely treatment, as fear of prosecution may delay diagnosis of reversible deficiencies like vitamin B12 depletion. Post-ban analyses reveal enforcement challenges, with historical precedents showing that restrictions since 2016 on non-medical sales merely shifted supply to informal networks without reducing prevalence, suggesting causal inefficacy in altering demand-driven behaviors absent education or alternatives. Environmental mitigation debates center on medical sector emissions, which represent a negligible share—less than 1% of global anthropogenic nitrous oxide—compared to agriculture's 70-75% contribution from fertilizers and manure management. The American Society of Anesthesiologists advocated in October 2024 for deactivating piped delivery systems in hospitals, transitioning to portable cylinders to curb venting losses that amplify the gas's 265-298 times greater warming potential over carbon dioxide, a strategy yielding over 50% emissions cuts in adopting facilities like those in NYC Health + Hospitals. However, scalability hinges on infrastructure costs and clinical workflow disruptions, with destruction technologies like catalytic converters facing feasibility hurdles due to nitrous oxide's chemical stability; empirical prioritization thus favors agricultural precision fertilization over medical curbs, as the latter yields marginal climate gains without broader soil and livestock reforms. Regulatory skeptics invoke individual liberties and market dynamics, projecting the nitrous oxide industry's expansion to $2.3 billion by 2030 amid rising medical and automotive demands, arguing that overreach stifles innovation without proportional benefits. Pro-ban advocates cite dual health and climate imperatives, but evidence from prohibition models indicates limited long-term efficacy, as usage persists via diversion and without tackling agricultural dominance, underscoring that mitigation success demands data-driven tradeoffs over punitive universality.

References

  1. [1]
    Nitrous Oxide | N2O | CID 948 - PubChem
    Nitrous oxide is a colorless, sweet-tasting gas. It is also known as laughing gas. Continued breathing of the vapors may impair the decision making process.
  2. [2]
    A Brief History of Nitrous Oxide (N2O) Use in Neuropsychiatry
    Joseph Priestley's discovery of nitrous oxide (N2O) was recorded in 1772. In the late 1790's, Humphry Davy experimented with the psychotropic properties of ...
  3. [3]
    Nitrous Oxide - StatPearls - NCBI Bookshelf
    Nitrous oxide can be used for general anesthesia, procedural sedation, dental anesthesia, and to treat severe pain. Nitrous oxide's potent analgesic properties ...
  4. [4]
    NITROUS OXIDE - CAMEO Chemicals - NOAA
    NITROUS OXIDE is a weak oxidizing agent. Nonflammable but supports combustion. Can explode at high temperature (after vaporization). Vapors can undergo a ...
  5. [5]
    Nitrous Oxide Emissions | US EPA
    Mar 20, 2025 · Nitrous Oxide Emissions. Properties of Nitrous Oxide. Chemical Formula: N2O Lifetime in Atmosphere: 114 years. Global Warming Potential (100 ...
  6. [6]
    Meta-Analysis of Environmental Impacts on Nitrous Oxide Release ...
    Atmospheric nitrous oxide (N2O) accounts for approximately 5% of the global greenhouse effect and destroys stratospheric ozone. Soils are the most important ...Missing: peer- | Show results with:peer-
  7. [7]
    What are the correct resonance structures of nitrous oxide?
    May 1, 2015 · In the resonance structures that you have drawn, both the nitrogen and oxygen on the ends are stable (having no charge) but nitrogen in the ...
  8. [8]
    N2O Resonance Structures - How to Draw Step by Step! - Topblogtenz
    Jul 10, 2025 · The two N-atoms are triple covalently bonded to each other while the O-atom is single-bonded to the central N-atom.
  9. [9]
    https://webbook.nist.gov/cgi/cbook.cgi?ID=C10024972
  10. [10]
    Nitrous oxide - Air Liquide Gas Encyclopedia
    Physical Properties ; Molar mass 44.013 g/mol; Content in dry air 0.33 ppm ; Critical Point. Temperature 36.42 °C; Pressure 72.45 bar; Density 451.88 kg/m³.
  11. [11]
    https://webbook.nist.gov/cgi/cbook.cgi?ID=C10024972&Mask=1
  12. [12]
    Nitrous oxide - the NIST WebBook
    Enthalpy of sublimation ; 24.6, 161. N/A, Blue and Giauque, 1935, Based on data from 148. to 182. K.; AC ; 23.6, 113. MG, Black, van Praagh, et al., 1930, Based ...
  13. [13]
    The thermal decomposition of nitrous oxide at pressures up to forty ...
    Nitrous oxide decomposes into nitrogen and oxygen at 600-850°C. The reaction is bimolecular, dependent on collisions, and activation energy is around 58,450 ...Missing: enthalpy | Show results with:enthalpy
  14. [14]
    Oxidation of Alkali-Metal Atoms with Nitrous Oxide - ACS Publications
    The reactions of nitrous oxide with alkali-metal atoms were studied theoretically by means of CASSCF(11/12)/MR-MP2 calculations.Introduction · Ground-State PES: General... · Collinear Reaction Cross...
  15. [15]
    https://www.csb.gov/assets/1/20/airgas_investigation_report_-_final_-_2017-02-28.pdf
  16. [16]
    [PDF] Nitrous Oxide Explosive Hazards - DTIC
    Jun 21, 2004 · Electrostatic discharge (ESD) has surfaced as a probable hazard for oxidizer flows over polymeric seals infused with high concentrations of N2O.
  17. [17]
    Mini-Review: A Brief History of Nitrous Oxide (N2O) Use in ... - NIH
    Joseph Priestley's discovery of nitrous oxide (N2O) was recorded in 1772. In the late 1790's, Humphry Davy experimented with the psychotropic properties of ...
  18. [18]
    Nitrous Oxide - Wood Library-Museum of Anesthesiology
    Nitrous Oxide gas (N2O) was first produced and described in 1772 by Joseph Priestley (1733–1804), a progressive English theologian, author and self taught ...
  19. [19]
    THE DISCOVERY OF NITROUS OXIDE AND OF OXYGEN
    In 1772 Priestley undoubtedly exposed nitrous air to a mixture of iron filings and sulphur, with water, which he found led to a considerable reduction in its ...
  20. [20]
    The Nitrous Oxide Experiments of Humphry Davy
    Mar 25, 2014 · In 1799 Humphry Davy, the young English chemist and inventor and future president of the Royal Society, began a very radical bout of self ...
  21. [21]
    Humphry Davy, laughing gas and the era of self-experimentation
    Feb 3, 2017 · When Humphry Davy wanted to explore the properties of nitrous oxide, he decided the best way would be to experiment upon himself.
  22. [22]
    Early misconceptions about nitrous oxide, an “invigorating” asphyxiant
    Nitrous oxide convulsions and all the nitrous oxide deaths that had occurred were the result of pure hypoxia” [1]. After what had been more than a century of ...
  23. [23]
    Horace Wells: A Pioneer in Modern Anesthesia and Pain-Free ... - NIH
    Oct 15, 2024 · Horace Wells discovered nitrous oxide as an anesthetic agent, which brought an emergent change in medical science. This breakthrough laid the ...Missing: analgesia | Show results with:analgesia
  24. [24]
    Horace wells' demonstration of nitrous oxide in Boston - PubMed
    Horace Wells, a dentist in Hartford, Connecticut, first used nitrous oxide in dentistry in December 1844. A few weeks later he travelled to Boston, ...Missing: analgesia | Show results with:analgesia
  25. [25]
    Horace Wells Discovers Pain-free Dentistry | a CTHumanities Project
    In December of 1844, Wells and his wife attended a demonstration at Union Hall in Hartford of “laughing gas” (nitrous oxide) put on by showman Gardner Colton, ...Missing: analgesia | Show results with:analgesia
  26. [26]
    A Brief History of Nitrous Oxide - Cerritos Dental Surgery
    Feb 4, 2014 · In the 1860s, nitrous oxide came into common usage in the United States, thanks primarily to Gardner Quincy Colton, a dentist whose Colton ...Missing: adoption | Show results with:adoption
  27. [27]
    Anesthesia and Entertainment: Nitrous Oxide in Nineteenth Century ...
    ... nitrous oxide demonstration was bound to fail, and how nitrous oxide came to be adopted as a surgical anesthetic in the 1860s. All of these questions are ...
  28. [28]
    PH Origins: Nitrous oxide injection - PistonHeads UK
    Mar 26, 2018 · Using nitrous required that the aircraft carry both a tank of oxidiser and a system to control its flow into the engine, resulting in a ...<|separator|>
  29. [29]
    The Anaesthesia Gas Supply System - PMC - PubMed Central - NIH
    Medical gases such as oxygen and air can be supplied in bulk and others such as nitrous oxide, medical air and entonox can be supplied from the cylinder ...Missing: war | Show results with:war
  30. [30]
    Past, present, and future of nitrous oxide - Oxford Academic
    Mar 8, 2018 · In their large, multicenter prospective study, Annequin et al. demonstrated the efficacy and safety of a 50% nitrous oxide/50% oxygen mixture ...Missing: war | Show results with:war
  31. [31]
    How Nitrous Oxide Plant Works - Medical Oxygen Generator
    Nitrous oxide is produced by thermally decomposing a hot solution of ammonium nitrate and water at concentrations varying from between 80 to 93%.
  32. [32]
    [PDF] SAFE PRACTICES FOR THE PRODUCTION OF NITROUS OXIDE ...
    In addition nitrous oxide gas in elevated concentrations can cause health effects in operators which should be prevented.
  33. [33]
    https://melscience.com/US-en/articles/methods-synthesis-nitrous-oxide/
  34. [34]
    APPENDIX I CURRENT METHODS OF COMMERCIAL ...
    The method currently used by British Oxygen for the production of nitrous oxide is described together with purification processes and tests for purity.
  35. [35]
    [PDF] CALCULATION OF EMISSIONS FROM A NITROUS OXIDE PLANT
    Typical consumption of ammonium nitrate is between 1.8 to 2 kg of ammonium nitrate per kg nitrous oxide. 4.2 Sources of emission. Typical nitrous oxide emission ...
  36. [36]
    US4154806A - Process for the production of nitrous oxide
    According to DT-PS No. 1 921 181 nitrous oxide is produced by decomposition of ammonium nitrate in aqueous, chloride-containing nitric acid solutions, in the ...
  37. [37]
    Nitrous oxide sources - Industry - GreenHouse Gas Online
    Nitrous oxide arises from adipic acid production during the oxidation of a ketone-alcohol mixture with nitric acid.Missing: method | Show results with:method
  38. [38]
    Nitrous Oxide Industry Report 2024 - Yahoo Finance
    Dec 6, 2024 · The global market for Nitrous Oxide was estimated at US$1.5 Billion in 2023 ... nitrous oxide in the production of nitric acid, which is a ...
  39. [39]
    Nitrous Oxide Market Size, Share & Growth Forecast 2035
    Sep 18, 2025 · Nitrous Oxide Market size was over USD 1.65 billion in 2025 and is anticipated to cross USD 3.53 billion by 2035, witnessing more than 7.9% CAGR ...
  40. [40]
    Nitric acid production costs? - Thunder Said Energy
    Our breakdown of nitric acid production costs sees marginal cost at $350/ton HNO3, CO2 intensity at 1.8 tons/ton, capex at $500/Tpa.
  41. [41]
    Thermal Decomposition of Ammonium Nitrate
    These results show that the decomposition of the ammonium nitrate to give N2O proceeds practic- ally entirely by a bond formation between the two nitrogen ...
  42. [42]
    How to Make Nitrous Oxide (Laughing Gas) - ThoughtCo
    Sep 8, 2019 · You can make nitrous oxide by gently heating ammonium nitrate between 170 to 240 degrees Celsius. It's important to use high-quality ammonium ...
  43. [43]
    Global nitrous oxide budget (1980–2020) - ESSD Copernicus
    Jun 11, 2024 · We estimate that total annual anthropogenic N2O emissions have increased 40 % (or 1.9 Tg N yr−1) in the past 4 decades (1980–2020). Direct ...
  44. [44]
    Atmospheric Concentrations of Greenhouse Gases | US EPA
    Global atmospheric concentrations of carbon dioxide, methane, nitrous oxide, and certain manufactured greenhouse gases have all risen significantly over the ...
  45. [45]
    Trends in N2O - Global Monitoring Laboratory
    Sep 5, 2025 · The graphs show globally-averaged, monthly mean atmospheric nitrous oxide abundance determined from marine surface sites.Missing: production | Show results with:production
  46. [46]
    Measuring and modeling the lifetime of nitrous oxide including its ...
    May 14, 2015 · The result is 116 ± 9 years. The observed monthly-to-biennial variations in lifetime and tropical abundance are well matched by four independent ...
  47. [47]
    Global Carbon Project-Led Study Shows Nitrous Oxide Emissions ...
    Jun 25, 2024 · “The growth rates of atmospheric nitrous oxide in 2020 and 2021 were higher than any previous observed year and more than 30 percent higher than ...Missing: trends | Show results with:trends
  48. [48]
    Changes in the Isotopic Signature of Atmospheric Nitrous Oxide and ...
    Aug 31, 2018 · The 15N/14N and 18O/16O isotope ratios were derived from m/z 45/m/z 44 and m/z 46/m/z 44 ion current ratios according to Kaiser et al. (2003) ...
  49. [49]
    The isotopic composition of atmospheric nitrous oxide observed at ...
    Jun 5, 2020 · We estimated the average isotopic signature of anthropogenic N2O sources with a two-box model to be -8.6±0.6 ‰ for δ15Nbulk, 34.8±3 ‰ for δ18O ...
  50. [50]
    Nitrous Oxide Production - an overview | ScienceDirect Topics
    Nitrous oxide production from soils has been linked to two biological processes. The first is during the process of nitrification of NH 4 + under aerobic ...
  51. [51]
    Nitrous oxide emissions from soils: how well do we understand the ...
    Although soil moisture has a predominant effect on N2O emission, it was found that denitrification is extremely sensitive to rising temperatures. The Q10 of ...
  52. [52]
    Nitrous oxide sources - Oceans - GreenHouse Gas Online
    Globally, oceans are thought to add around 3 million tonnes of nitrous oxide-N to the atmosphere each year. Like methane, much of the nitrous oxide in the ...<|control11|><|separator|>
  53. [53]
    The Global Nitrous Oxide Budget 2024 - IIASA
    Jun 12, 2024 · The study shows that the concentration of atmospheric nitrous oxide reached 336 parts per billion in 2022, a 25% increase over pre-industrial ...
  54. [54]
    Warming intensified the effects of nitrogen addition on N2O ...
    A combined effect of warming and N-addition of resulted in 208.6% (2018) and 90.8% (2019) increase in N2O emissions, respectively, compared to the individual ...
  55. [55]
    Green rocket propulsion: overview of nitrous oxide applications with ...
    Oct 10, 2025 · Very high specific impulse in both liquid bipropellant and hybrid propulsion systems ... Cfd simulations of self-pressurized nitrous oxide hybrid ...
  56. [56]
    Investigation of Performance Stability of a Nytrox Hybrid Rocket ...
    Nitrous oxide is a highly suitable oxidizer for hybrid rockets due to its self-pressurizing properties, moderate cost, and high accessibility.
  57. [57]
    Study of Suborbital Rocket Plane Using Highly Pressurized ...
    Jun 13, 2025 · For SpaceShipOne's engine, the specific impulse efficiency was estimated at 0.87, based on reference data including empty and loaded weights, ...
  58. [58]
    [PDF] n2o propulsion research at tsinghua: 2006 - IBB.ch
    HYBRID ROCKET MOTOR. Hybrid rocket motor using nitrous oxide is capable of higher specific impulse performance (Figure 5) than the monopropellant thruster.
  59. [59]
    Hybrid Rocket Motor Design – - Space Safety Magazine
    Nov 1, 2014 · Nitrous oxide can also be catalyzed into decomposition and explosion by many substances, notably iron oxide (rust).
  60. [60]
    Everything You Need to Know About Nitrous Oxide
    Jun 12, 2019 · Street kits usually add between 50 and 250 horsepower, for as little as $500. When properly installed, nitrous is the best horsepower-per-dollar ...
  61. [61]
    The Facts About Nitrous Oxide Injection - HOT ROD
    It is the simplest, most direct bolt-on system and it can provide all the power increase your engine can possibly use unless it has been built for all-out drag ...
  62. [62]
    Nitrous History - V8buick.com
    Sep 30, 2018 · The technique was used during World War II by Luftwaffe aircraft with the GM-1 system to boost the power output of aircraft engines.
  63. [63]
    Meet the Father of NOS: Mike Thermos | ClassicCars.com Journal
    Jul 31, 2020 · The guy behind the widespread use of Nitrous Oxide in dragsters and street racers with NOS is Mike Thermos.
  64. [64]
    After 20 Years of Drag-and-Drive History, Nitrous Oxide Systems ...
    Nov 16, 2024 · Nitrous oxide is a cheap, easy power adder, used in the first drag-and-drive event, and was used in the first 6-second and 200 mph quarter-mile ...
  65. [65]
    Nitrous Oxide Science: Behind Perfect Whipped Cream - FastGas
    May 5, 2024 · It is more soluble in fat than gases like nitrogen (N2) or oxygen (O2), allowing it to dissolve efficiently in the cream's fat content. This ...
  66. [66]
    Whipped cream use nitrous oxide instead of nitrogen gas. What can ...
    Oct 26, 2018 · Due to its solubility in fats, N2O is able to foam whipped cream up to four times the original liquid volume, whereas with air or nitrogen ...What properties of nitrous oxide make it a good propellant ... - QuoraWhy do whipped cream companies use nitrous oxide as a propellant ...More results from www.quora.com
  67. [67]
    [PDF] Instant Foam Physics - WUR eDepot
    Due to the high pressure in an aerosol can (5-10 bar) the nitrous oxide is for the larger part dissolved in the cream. It is recommended to shake the can ...
  68. [68]
    FDA Advises Consumers Not to Inhale Nitrous Oxide Products
    Jun 4, 2025 · ... propellant for whipped cream and culinary food use. Intentional misuse or inhalation of contents can lead to serious adverse health events ...Missing: GRAS history
  69. [69]
    Nitrous Oxide Cream Charger Unlocking Growth Opportunities
    Rating 4.8 (1,980) May 11, 2025 · Nitrous oxide cream chargers represent a multi-million-unit market, with annual global sales exceeding 250 million units. Concentration is ...
  70. [70]
    The impact of gas mixtures of Argon and Nitrous oxide (N 2 O) on ...
    Nitrous oxide (N2O) has been found to have effect on inhibition of respiration and senescence in higher plants showing high potentiality for the packaging of ...
  71. [71]
    Food Grade Nitrous Oxide Market Size, Scope, & Forecast
    Rating 4.5 (43) Food Grade Nitrous Oxide Market size was valued at $ 1.18 Bn in 2024 and is expected to reach $ 1.81 Bn by 2032, growing at a CAGR of 5.5% from 2026 to ...
  72. [72]
    To Use or Not to Use Nitrous Oxide - Clinical View by GE HealthCare
    Aug 1, 2022 · Nitrous oxide also enhances the speed of onset of other volatile anesthetic agents through the 'second gas effect'. Because of nitrous oxide's ...
  73. [73]
    Nitrous Oxide - OpenAnesthesia
    Jul 1, 2024 · Nitrous oxide induces analgesia by activating opioidergic in the periaqueductal grey matter and noradrenergic neurons in the locus ceruleus.1.Missing: potentiates | Show results with:potentiates
  74. [74]
    Success rate of nitrous oxide-oxygen procedural sedation in dental ...
    The aim of this systematic review was to determine the success rate of nitrous oxide-oxygen procedural sedation (NOIS) in dentistry.
  75. [75]
    Comparative evaluation of efficacy and safety of nitrous oxide and ...
    May 30, 2025 · This systematic review and meta-analysis aimed to consolidate the most robust evidence on the efficacy and safety of nitrous oxide versus midazolam for ...<|separator|>
  76. [76]
    Is nitrous oxide an effective monotherapy for labor pain? - LWW
    Yes. Nitrous oxide monotherapy is an effective modality for reducing labor pain by as much as 3 to 5 points on a 10-point pain scale compared with placebo.
  77. [77]
    ​Nitrous Oxide | American Society of Anesthesiologists (ASA)
    Nitrous oxide has been used throughout the world for labor pain control for many decades and is considered safe.Missing: post- war
  78. [78]
    Pro‐Con Debate: Nitrous Oxide for Labor Analgesia - Vallejo - 2019
    Aug 20, 2019 · Nitrous oxide provides a similar level of pain relief as compared to a paracervical block and opioids but does not have the side effects on the ...
  79. [79]
    Nitrous Oxide for Labor Analgesia: What We Know to Date - PMC - NIH
    N 2 O has been shown to be a safe option for both mom and baby during labor and delivery. Studies support N 2 O as an analgesic for laboring.
  80. [80]
    High-Concentration Nitrous Oxide for Procedural Sedation in Children
    Mar 1, 2008 · Sixty-three (8.3%) patients sustained 70 mild and self-resolving adverse events, most of which were vomiting (5.7%); 2 (0.2%) patients had ...
  81. [81]
    How Medical Nitrous Oxide Works — In One Simple Flow (2025)
    Oct 14, 2025 · Automation, AI-driven monitoring, and IoT connectivity will become standard features, enhancing precision and safety. Key accelerators include ...
  82. [82]
    Nitrous-Oxide Sedation Machine Market Size and Forecast
    Rating 4.7 (62) Innovations like automated gas flow control, digital flowmeters, and real-time sedation monitoring are enhancing safety and usability, particularly in pediatric ...By Product Type · By Application · By Technology<|control11|><|separator|>
  83. [83]
    Nitrous oxide (laughing gas) is an NMDA antagonist ... - PubMed - NIH
    Here we show that N2O, at anesthetically-relevant concentrations, inhibits both ionic currents and excitotoxic neurodegeneration mediated through NMDA receptors ...
  84. [84]
    Nitrous oxide (N2O) requires the N-methyl-d-aspartate receptor for ...
    N2O does strongly antagonize NMDA receptors and does not potentiate GABAA receptors; however, other untested mechanisms might be responsible for some or all of ...
  85. [85]
    Neurobiology of nitrous oxide-induced antinociceptive effects
    Evidence to date indicate that N2O induces opioid peptide release in the periaqueductal gray area of the midbrain leading to the activation of the descending ...Missing: dopamine | Show results with:dopamine
  86. [86]
    Opioid Effects of Psychotropic Analgesic Nitrous Oxide on th... - LWW
    To the Editor: The work by Murakawa et al. gives further support for the actions of nitrous oxide on influencing dopamine (DA) activity. Opioids can also ...
  87. [87]
    Effects of nitrous oxide on MAC - ScienceDirect.com
    The MAC of nitrous oxide is 1·04 atmospheres absolute (corresponding to 104 vol%). The MAC criterion has served since the early 1960s as a gold standard to ...
  88. [88]
    Nitrous Oxide Administration: Overview, Indications, Contraindications
    Oct 29, 2022 · In dentistry, nitrous oxide is indicated to decrease the pain and anxiety associated with procedures. ... A meta-analysis. Anesthesiology ...Missing: VAS | Show results with:VAS
  89. [89]
    Nitrous Oxide (Whippet) Abuse, Side Effects & Treatment
    Dec 31, 2024 · Read on to learn more about nitrous oxide (whippets) and how it is often abused. Learn about the effects and the dangers of nitrous oxide ...<|separator|>
  90. [90]
    Galaxy Gas: Flavored Whipped Cream Charger Or Dangerous Drug?
    Galaxy Gas is an Atlanta-based brand of nitrous oxide, an odorless, colorless, non-flammable gas also known as “laughing gas” or “whippits,” typically ...
  91. [91]
    Dangerous Trend: Galaxy Gas | | CIRP
    Oct 8, 2024 · The dangers of misusing nitrous oxide (often dubbed “Galaxy Gas,” named after one of the companies that manufactures whipped cream canisters) include headache, ...Missing: 2023 | Show results with:2023
  92. [92]
    Nitrous Oxide Inhalation Among Adolescents: Prevalence ... - NIH
    Lifetime prevalence of NO use was 15.8%. NO+VS users evidenced greater impairments compared to NO+VS nonusers. VS-only users evidenced impairments that were ...
  93. [93]
    Researchers Concerned About Rise in Nitrous Oxide Misuse, Deaths
    Apr 2, 2025 · More than 13 million Americans have misused nitrous oxide in their lifetimes, according to the 2023 National Survey on Drug Use and Health. The ...Missing: prevalence youth
  94. [94]
    Nitrous oxide: Doctors warn of “epidemic” of use by young people
    Sep 5, 2022 · The 2019-20 Crime Survey for England and Wales found that almost 9% of 16-24 year olds said that they had taken nitrous oxide in the previous ...Missing: prevalence | Show results with:prevalence
  95. [95]
    Nitrous oxide - Alcohol and Drug Foundation
    Jun 6, 2025 · Nitrous oxide is a colourless gas commonly used for sedation and pain relief. 1 Dentists and medical professionals use it to sedate patients having minor ...What is nitrous oxide? · Effects of nitrous oxide · Overdose · Long-term effects
  96. [96]
    The rise of nitrous oxide abuse. An international survey of ... - PubMed
    N2O was generally consumed via gas-filled balloons, at festivals and clubs where use of other substances was common. The vast majority of users use infrequently ...
  97. [97]
    A Systematic Review of Recreational Nitrous Oxide Use - NIH
    N2O was identified as a very commonly used drug in the UK and US with one study noting prevalence of use in the population up to 38% [33]. All studies except ...
  98. [98]
    Nitrous Oxide Cream Charger Market Research Report 2035
    Aug 6, 2025 · The Nitrous Oxide Cream Charger Market is expected to grow from 510.2 USD Million in 2025 to 1,000 USD Million by 2035. The Nitrous Oxide Cream ...
  99. [99]
    Nitrous Oxide Cream Charger Market By Application 2025 - LinkedIn
    Sep 7, 2025 · The global Nitrous Oxide Cream Charger market is estimated at approximately USD 850 million in 2025, with a projected CAGR of 6.2% from 2025 to ...
  100. [100]
    Nitrous Oxide-Induced Vitamin B12 Deficiency Resulting in ...
    Jul 9, 2020 · Nitrous oxide use can cause vitamin B12 deficiency, resulting in neurologic manifestations such as myeloneuropathy and subacute combined ...
  101. [101]
    Nitrous oxide abuse and associated neurological diseases - PMC
    Nov 26, 2024 · Seven patients with nitrous oxide induced neurological disease are reported. All patients present with acute myelopathy and sensorimotor polyneuropathy.
  102. [102]
    Electrophysiologic characteristics of nitrous-oxide-associated
    Jan 2, 2023 · N 2 O-associated peripheral neuropathy can lead to sensory and motor nerve injury, with axonal injury being the most common.
  103. [103]
    Nitrous oxide-induced subacute combined degeneration of the cord
    A pattern of myeloneuropathy usually associated with severe vitamin B 12 deficiency. This can cause serious and permanent disability in young people.
  104. [104]
    NITROUS OXIDE-INDUCED VITAMIN B12 MYELOPATHY - SHM ...
    Apr 5, 2023 · It is important to consider N2O abuse as a cause of acute dorsal column myelopathy, as symptoms can improve or be reversed with high dose vitamin B12 ...
  105. [105]
    Nangs, balloons and crackers: Recreational nitrous oxide neurotoxicity
    Nitrous oxide exerts its neurotoxicity through vitamin B12 inactivation, which disrupts myelin sheath maintenance, leading to peripheral and central nervous ...<|separator|>
  106. [106]
    Myelopathy Caused by Nitrous Oxide Toxicity
    Myeloneuropathy is caused by inactivation of vitamin B12 by nitrous oxide. This syndrome can also be seen in patients with borderline vitamin B12 deficiency ...
  107. [107]
    Asphyxial deaths from the recreational use of nitrous oxide - PubMed
    Twenty previously described deaths associated with recreational nitrous-oxide use describe anesthesia tanks and whipped-cream machine dispensors as a source.Missing: trends | Show results with:trends
  108. [108]
    US Nitrous Oxide Mortality - PMC
    Jul 30, 2025 · From 2010 to 2023, there was a total of 1240 deaths attributable to nitrous oxide poisoning among people aged 15 to 74 years in the US, with 23 ...
  109. [109]
    Deaths From Popular School Drug Spike by More Than 500%
    Jul 31, 2025 · The duo's analysis revealed that nitrous oxide deaths have increased by 578 percent—from 23 in 2010 to 156 in 2023. The study began early in ...Missing: statistics | Show results with:statistics
  110. [110]
    [PDF] Nitrous Oxide - NJ.gov
    * Contact with liquefied Nitrous Oxide may cause skin burns and/or frostbite. * Breathing Nitrous Oxide can irritate the eyes, nose and throat causing coughing ...Missing: LD50 | Show results with:LD50<|separator|>
  111. [111]
    Nitrous Oxide Overdose Symptoms - Oxford Treatment Center
    Jun 20, 2025 · Nitrous Oxide Side Effects · Dizziness. · Dissociation (feeling as if one is not attached to one's body or that one is not real). · Irrational ...
  112. [112]
    Nitrous oxide: Uses, Interactions, Mechanism of Action - DrugBank
    AMES toxic, 0.7381. Carcinogenicity, Carcinogens, 0.6906. Biodegradation, Ready biodegradable, 0.9704. Rat acute toxicity, 2.8320 LD50, mol/kg, Not applicable.
  113. [113]
    Nitrous oxide - NIOSH Pocket Guide to Chemical Hazards - CDC
    Nitrous oxide · Exposure Limits. NIOSH REL. TWA 25 ppm (46 mg/m3) (TWA over the time exposed) [*Note: REL for exposure to waste anesthetic gas.] OSHA PEL. none.
  114. [114]
    Toxicity of nitrous oxide - ScienceDirect.com
    Long-term exposure to high concentrations of nitrous oxide may cause megaloblastic bone-marrow depression and neurological symptoms.Missing: reproductive | Show results with:reproductive
  115. [115]
    Health Effects Associated With Exposure to Anesthetic Gas Nitrous ...
    Nitrous oxide can also cause depression of leukocyte production, their motility, and leukocytes chemotaxis, which indirectly affects cellular immunity.
  116. [116]
    Reduced Fertility among Women Employed as Dental Assistants ...
    Oct 1, 1992 · We found an association between occupational exposure to high levels of unscavenged nitrous oxide and reduced fertility in female dental ...Missing: hematologic | Show results with:hematologic
  117. [117]
    Nitrous oxide–induced reproductive risks: Should recreational ... - NIH
    May 5, 2022 · Adverse reproduction effects included congenital anomalies, spontaneous abortion and reduced fertility rates in females.
  118. [118]
    Nitrous Oxide | NIOSH - CDC Archive
    Apr 24, 2018 · Long-term exposure can lead to infertility. Contact with liquid nitrous oxide can cause severe frostbite. Workers may be harmed from exposure to ...<|separator|>
  119. [119]
    ICSC 0067 - NITROUS OXIDE
    Not combustible but enhances combustion of other substances. Gives off irritating or toxic fumes (or gases) in a fire. Risk of fire and explosion. See Chemical ...Missing: asphyxiation | Show results with:asphyxiation
  120. [120]
    [PDF] Nitrous Oxide | Material Safety Data Sheet
    Apr 1, 2013 · This material increases the risk of fire and may aid combustion. In a fire or if heated, a pressure increase will occur and the container may ...Missing: occupational asphyxiation
  121. [121]
    Accident Report Detail | Occupational Safety and Health ... - OSHA
    Abstract: Four Employees were working near a cylinder that was venting a mixture of saline and nitrous oxide when it exploded. All four employees were ...
  122. [122]
    [PDF] Nitrous Oxide Explosion - Chemical Safety Board
    Aug 28, 2016 · Contamination can lower the safe operating limit conditions for the nitrous oxide decomposition reaction. The exact effect of contamination on ...
  123. [123]
    European Society of Anaesthesiology Task Force on Nitrous Oxide
    Feb 21, 2019 · A meta-analysis suggesting an increased rate of spontaneous abortion in female health workers exposed to anaesthetic gases used data before ...
  124. [124]
    a survey of anesthetic gas safety - PMC - NIH
    Dec 3, 2022 · Potential implications of exposure could lead to chromosomal aberrations, sister chromatid exchanges, comet assays, spontaneous abortions, and ...
  125. [125]
    https://www.osha.gov/waste-anesthetic-gases/workplace-exposures-guidelines
  126. [126]
    [PDF] A health-based recommended occupational exposure limit for ... - Pure
    Jun 23, 2021 · The health-based recommended occupational exposure limit for nitrous oxide is 20 mg/m3 as an 8-h time-weighted average.
  127. [127]
    What Safety Gear Is Used for Nitrous Oxide Work?
    To protect against nitrous oxide exposure, you'll need a detailed eye and face protection system that meets ANSI/ISEA Z87.1-2010 standards. When handling liquid ...
  128. [128]
    [PDF] SAFETY DATA SHEET - Airgas
    Fire-fighters should wear appropriate protective equipment and self-contained breathing apparatus (SCBA) with a full face-piece operated in positive pressure ...
  129. [129]
    [PDF] safe practices for storage and handling of nitrous oxide - EIGA
    In addition, nitrous oxide gas in elevated concentrations can cause health effects in personnel, which shall be prevented.
  130. [130]
    Projectile Cylinder Accidents Resulting from the Presence of ...
    Five accidents involving projectile tanks of anesthetic nitrous oxide or oxygen for patient life support occurred from 2-15 years after installation of the MR ...
  131. [131]
    Chapter 7: The Earth's Energy Budget, Climate Feedbacks, and ...
    One metric, the 100-year global warming potentials (GWP-100), has extensively been employed in climate policy to report emissions of different GHGs on the ...
  132. [132]
    Understanding Global Warming Potentials | US EPA
    Jan 16, 2025 · Nitrous Oxide (N2O) has a GWP 273 times that of CO2 for a 100-year timescale. N2O emitted today remains in the atmosphere for more than 100 ...
  133. [133]
    [PDF] A Primer on Anthropogenic Nitrous Oxide:
    Oct 1, 2024 · 2545–2546 (“Unlike anthropogenic emissions, global natural land and ocean N2O emissions were relatively stable. According to the BU ...
  134. [134]
    Global nitrous oxide budget (1980–2020)
    Jun 20, 2024 · ... contribution of N2O to the total enhanced effective radiative forcing of greenhouse gases was 6.4 % for 1750–2022. As a core component of ...
  135. [135]
    Agriculture 'major driver' of rise in nitrous oxide emissions over past ...
    Jun 11, 2024 · Nitrogen fertilisers, manure and other agricultural sources drove almost three-quarters of human-caused nitrous oxide emissions in recent years.
  136. [136]
    [PDF] WMO Greenhouse Gas Bulletin. No 1
    Oct 16, 2025 · The globally averaged. N2O concentration reached 338.0 ±0.1 ppb in 2024, which is an increase of 1.0 ppb with respect to the previous year ...
  137. [137]
    The changing ozone depletion potential of N 2 O in a future climate
    Nov 23, 2015 · N2O is destroyed mainly in the stratosphere, where it can either be photolyzed or undergo reaction with excited atomic oxygen (O(1D)). This ...Abstract · Introduction · Computational Methods · Results and Discussion
  138. [138]
    Stratospheric ozone depletion due to nitrous oxide - NIH
    Anthropogenic influence on ozone occurs via changes in the emission of source gases. These source gas changes can affect all of the chemical families both ...
  139. [139]
    Rise in nitrous oxide emissions endangers pathway to 1.5°C ... - UNEP
    Nov 12, 2024 · Nitrous oxide is currently the most significant ozone-layer depleting substance being emitted into the atmosphere. The Assessment shows that ...Missing: mechanism | Show results with:mechanism
  140. [140]
    Science: Nitrous Oxide Emissions Now the Most Significant Threat to ...
    The results of the study indicate that nitrous oxide has become the largest and most significant ozone-depleting substance emitted by human activities—and it is ...Missing: mechanism | Show results with:mechanism<|separator|>
  141. [141]
    Nitrate‐Driven Eutrophication Supports High Nitrous Oxide ...
    Apr 3, 2025 · Eutrophication stimulates nitrous oxide emissions in coastal lagoons · Excess nitrate induces incomplete denitrification, leading to high nitrous ...
  142. [142]
    N2O emissions fueled by eutrophication in a shallow lake
    Mar 28, 2025 · These findings demonstrate the role of eutrophication in influencing the N 2 O dynamics and confirm that eutrophication can exacerbate N 2 O emissions.
  143. [143]
    Laughing Gas Is No Joke: The Forgotten Greenhouse Gas | Article
    Dec 1, 2022 · Small yet mighty, nitrous oxide accounted for seven percent of all U.S. anthropogenic greenhouse gas emissions in 2020. And these emissions are ...Missing: peer- | Show results with:peer-
  144. [144]
    [PDF] Pre-review report: Nitrous oxide - World Health Organization (WHO)
    The remainder inhaled nitrous oxide from whipped cream dispensers (12.8 ... fat soluble (155–157). It is approved for use as a food additive by most ...
  145. [145]
    Addressing the unregulated use of nitrous oxide canisters
    In the United States, misuse has been steadily rising since 2010, and from 2023 to 2024, there was a 58 % increase in intentional nitrous oxide exposure reports ...
  146. [146]
    Nothing to Laugh About: Nitrous Oxide Misuse and the Need for a ...
    Apr 30, 2025 · Overview. There are legitimate and safe uses of the gas nitrous oxide for medical, culinary arts and industrial use. However, recreational use ...
  147. [147]
    Nitrous Oxide - MOST Policy Initiative
    Dec 30, 2024 · Twelve states specifically prohibit possession and sale of nitrous oxide for recreational use, but MO does not.Missing: DEA | Show results with:DEA
  148. [148]
    Nitrous oxide ban: guidance - GOV.UK
    Nov 8, 2023 · We are updating the law to make possession of nitrous oxide illegal from 8 November 2023 if it is, or is likely to be, wrongfully inhaled.Missing: EU | Show results with:EU
  149. [149]
    What is nitrous oxide and why is it being banned? - BBC
    Apr 11, 2024 · Nitrous oxide is now a Class C drug under the Misuse of Drugs Act 1971, making possession and sale for recreational purposes a criminal offence.Missing: UN | Show results with:UN
  150. [150]
    Nitrous oxide - WA Health
    Oct 31, 2024 · The government has amended the Medicines and Poisons Regulations 2016 to restrict access to nitrous oxide. Under the new regulations, nitrous ...
  151. [151]
    Responsible sale of solvents - Health.vic
    Jul 7, 2025 · From 1 October 2022 nitrous oxide products for non-therapeutic use have been classified as Schedule 6 by the Therapeutic Goods Association.
  152. [152]
    Nitrous oxide: Laughing gas ban could harm users, experts warn
    Aug 30, 2023 · The proposed ban of nitrous oxide could stop users seeking medical help in hospitals, health experts have warned.
  153. [153]
    Experts condemn government's decision to criminalise nitrous oxide ...
    Mar 27, 2023 · Medical experts and substance abuse charities have condemned the government's decision to criminalise nitrous oxide, commonly known as laughing gas.
  154. [154]
    Why criminalising nitrous oxide is a mistake | Transform
    Sep 7, 2023 · The Government has decided to criminalise the possession of nitrous oxide for personal use as part of its crackdown on antisocial behaviour.<|separator|>
  155. [155]
    Tackling the growing burden of nitrous oxide-induced public health ...
    Feb 7, 2025 · The UK Government reviewed their legislation on nitrous oxide in 2023. Before 2023, legislation under the 2016 Psychoactive Substances Act meant ...<|separator|>
  156. [156]
    Persistent use of nitrous oxide for anaesthesia in European ...
    Dec 11, 2023 · Furthermore, it should be noted that the share of medical nitrous oxide emissions is relatively small compared to those caused by agriculture. ...
  157. [157]
    Statement on Deactivating Central Piped Nitrous Oxide to Mitigate ...
    Oct 23, 2024 · The ASA recommends the deactivation of central piped N 2 O delivery systems and the transition to portable N 2 O supply systems for all clinical use.
  158. [158]
    NYC Health + Hospitals Cuts Annual Anesthesia-Related Carbon ...
    Apr 16, 2025 · NYC Health + Hospitals Cuts Annual Anesthesia-Related Carbon Emissions by Over 50% through Deactivation of Central Piped Nitrous Oxide Systems.
  159. [159]
    Tackling the growing burden of nitrous oxide-induced public health ...
    Use is highest among people aged 16–24 years, although prevalence estimates could be inaccurate due to the voluntary nature of surveys. Among people aged 16–24 ...<|separator|>
  160. [160]
    Nitrous Oxide Market Size To Reach $2.30 Billion By 2030
    The global nitrous oxide market size is expected to reach USD 2.30 billion by 2030, registering a CAGR of 7.9% from 2023 to 2030, according to a new report ...
  161. [161]
    Today's ban on 'laughing gas' is wrong - Prof David Nutt
    Nov 8, 2023 · “We believe the ban is wrong. It is completely disproportionate to nitrous oxide's harms. It will place a new burden on an already overstretched ...<|separator|>